BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 29207078)

  • 21. Association of LTBR polymorphisms with chronic hepatitis B virus infection and hepatitis B virus-related hepatocellular carcinoma.
    Zhu Q; Li N; Li F; Sang J; Deng H; Han Q; Lv Y; Li C; Liu Z
    Int Immunopharmacol; 2017 Aug; 49():126-131. PubMed ID: 28575727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The -94Ins/DelATTG polymorphism in NFκB1 promoter modulates chronic hepatitis C and liver disease progression.
    Fakhir FZ; Lkhider M; Badre W; Alaoui R; Pineau P; Ezzikouri S; Benjelloun S
    Infect Genet Evol; 2016 Apr; 39():141-146. PubMed ID: 26827631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL17A gene polymorphisms: relationship to predisposition for chronic viral hepatitis and progression to liver cirrhosis in kazakh population.
    Massabayeva MR; Aukenov NE; Mussazhanova ZB; Saenko VA; Rogounovitch TI; Shaimardanov NK; Kurmanova BR; Barkibaeva NR; Rakhypbekov TK
    Vopr Virusol; 2016; 61(5):212-9. PubMed ID: 29323853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
    Abbas E; Shaker O; Abd El Aziz G; Ramadan H; Esmat G
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):458-63. PubMed ID: 22293333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
    Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
    Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of interleukin-1beta genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan.
    Tanaka Y; Furuta T; Suzuki S; Orito E; Yeo AE; Hirashima N; Sugauchi F; Ueda R; Mizokami M
    J Infect Dis; 2003 Jun; 187(11):1822-5. PubMed ID: 12751042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of XRCC1, XRCC3, and XPD genetic polymorphism with an increased risk of hepatocellular carcinoma because of the hepatitis B and C virus.
    Gulnaz A; Sayyed AH; Amin F; Khan Au; Aslam MA; Shaikh RS; Ali M
    Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):166-79. PubMed ID: 23044807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Independent and additive interaction between polymorphisms of tumor necrosis factor α-308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B.
    Tsai JF; Chen SC; Lin ZY; Dai CY; Huang JF; Yu ML; Chuang WL
    Kaohsiung J Med Sci; 2017 Sep; 33(9):453-457. PubMed ID: 28865603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus genotype, mutations, human leukocyte antigen polymorphisms and their interactions in hepatocellular carcinoma: a multi-centre case-control study.
    Wen J; Song C; Jiang D; Jin T; Dai J; Zhu L; An J; Liu Y; Ma S; Qin N; Liang C; Chen J; Jiang Y; Yang L; Liu J; Liu L; Geng T; Chen C; Jiang J; Chen J; Zhu F; Zhu Y; Yu L; Shen H; Zhai X; Xu J; Hu Z
    Sci Rep; 2015 Nov; 5():16489. PubMed ID: 26568165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.
    Sonzogni L; Silvestri L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Bottelli R; Mondelli MU; Civardi E; Silini EM
    Hepatology; 2002 Jul; 36(1):195-201. PubMed ID: 12085365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD81 nucleotide mutation in hepatocellular carcinoma and lack of CD81 polymorphism in patients at stages of hepatitis C virus infection.
    Itakura J; Nagayama K; Enomoto N; Sakamoto N; Tazawa J; Izumi N; Marumo F; Sato C
    J Med Virol; 2001 Jan; 63(1):22-8. PubMed ID: 11130883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma.
    Agúndez JA; García-Martín E; Devesa MJ; Carballo M; Martínez C; Lee-Brunner A; Fernández C; Díaz-Rubio M; Ladero JM
    Oncology; 2012; 82(1):35-40. PubMed ID: 22286521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma.
    Cheong JY; Shin HD; Cho SW; Kim YJ
    J Korean Med Sci; 2014 Nov; 29(11):1523-7. PubMed ID: 25408584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-6-174 Promoter Polymorphism and Susceptibility to Hepatitis B Virus Infection as a Risk Factor for Hepatocellular Carcinoma in Iran.
    Attar M; Azar SS; Shahbazi M
    Asian Pac J Cancer Prev; 2016; 17(5):2395-9. PubMed ID: 27268603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Polymorphisms of Cytochrome P4501A1 (CYP1A1) and Glutathione S-Transferase P1 (GSTP1) and Risk of Hepatocellular Carcinoma Among Chronic Hepatitis C Patients in Egypt.
    Abo-Hashem EM; El-Emshaty WM; Farag Rel S; Zakaria S; Abd El-Aziz M; Ghonaim A
    Biochem Genet; 2016 Oct; 54(5):696-713. PubMed ID: 27271262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma.
    Qiu M; Liu Y; Yu X; Qin L; Bei C; Zeng X; Qiu X; Tang B; He S; Yu H
    Tumour Biol; 2016 Mar; 37(3):3863-70. PubMed ID: 26476535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variants underlying vitamin D metabolism and VDR-TGFβ-1-SMAD3 interaction may impact on HCV progression: a study based on dbGaP data from the HALT-C study.
    de Azevedo LA; Matte U; da Silveira TR; Álvares-da-Silva MR
    J Hum Genet; 2017 Nov; 62(11):969-977. PubMed ID: 28703134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Association of interleukin-12 gene polymorphism with persistence of hepatitis B virus infection and hepatocellular carcinoma].
    Park JS; Cheong JY; Kang JK; Cho JH; Yu S; Shin HD; Park BL; Cho SW
    Korean J Gastroenterol; 2007 Nov; 50(5):313-8. PubMed ID: 18159163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of single nucleotide polymorphisms in microRNAs with susceptibility to hepatitis B virus infection and HBV-related liver complications: A study in a Saudi Arabian population.
    Al-Qahtani AA; Al-Anazi MR; Nazir N; Wani K; Abdo AA; Sanai FM; Khan MQ; Al-Ashgar HI; Albenmousa A; Al-Hamoudi WK; Alswat KA; Al-Ahdal MN
    J Viral Hepat; 2017 Dec; 24(12):1132-1142. PubMed ID: 28685993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between TNF alpha gene polymorphisms (-238/-308), TNF RII VNTR (p75) and outcomes of hepatitis B virus infection in Tunisian population.
    Sghaier I; Zidi S; Mouelhi L; Dabbech R; Ghazouani E; Brochot E; Stayoussef M; Yacoubi-Loueslati B
    Gene; 2015 Sep; 568(2):140-5. PubMed ID: 25982858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.